Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK-guided dose-adjusted 5-fluorouracil in metastatic colorectal cancer
2011-003553-26Phase 4Completed
- Sponsor
- Central European Society for Anticancer Drug Research
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fluorouracil in metastatic colorectal adenocarcinoma (mCRC), sponsored by Central European Society for Anticancer Drug Research. Started Feb 2012; status: completed.
02
Drugs
fluorouracil
03
Conditions
metastatic colorectal adenocarcinoma (mCRC)
Beyond the preview
Go deeper on 2011-003553-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003553-26.